Ketoconazole transdermal - Phosphagenics

Drug Profile

Ketoconazole transdermal - Phosphagenics

Alternative Names: Ketoconazole TPM®; TPM/ketoconazole

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Phosphagenics
  • Class Antifungals; Azoles; Piperazines; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Seborrhoeic dermatitis

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Seborrhoeic-dermatitis in Australia (Transdermal, Patch)
  • 30 Sep 2013 Preclinical trials in Seborrhoeic dermatitis in Australia (Transdermal)
  • 30 Aug 2013 Preclinical trials in Undefined indication in Australia (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top